Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Effects of mood stabilizers on marble-burying behavior in mice: involvement of GABAergic system.

Egashira N, Abe M, Shirakawa A, Niki T, Mishima K, Iwasaki K, Oishi R, Fujiwara M.

Psychopharmacology (Berl). 2013 Mar;226(2):295-305. doi: 10.1007/s00213-012-2904-9. Epub 2012 Oct 21.

PMID:
23086022
2.

Perospirone, a novel antipsychotic drug, inhibits marble-burying behavior via 5-HT1A receptor in mice: implications for obsessive-compulsive disorder.

Matsushita M, Egashira N, Harada S, Okuno R, Mishima K, Iwasaki K, Nishimura R, Fujiwara M.

J Pharmacol Sci. 2005 Oct;99(2):154-9. Epub 2005 Oct 6.

3.

N-acetyl-L-cysteine inhibits marble-burying behavior in mice.

Egashira N, Shirakawa A, Abe M, Niki T, Mishima K, Iwasaki K, Oishi R, Fujiwara M.

J Pharmacol Sci. 2012;119(1):97-101. Epub 2012 Apr 18.

4.

Combination of aripiprazole and ethanol attenuates marble-burying behavior in mice.

Gaikwad U, Parle M.

Acta Pol Pharm. 2011 May-Jun;68(3):435-40.

5.

Aripiprazole inhibits marble-burying behavior via 5-hydroxytryptamine (5-HT)1A receptor-independent mechanisms.

Egashira N, Okuno R, Matsushita M, Abe M, Mishima K, Iwasaki K, Nishimura R, Oishi R, Fujiwara M.

Eur J Pharmacol. 2008 Sep 11;592(1-3):103-8. doi: 10.1016/j.ejphar.2008.06.100. Epub 2008 Jul 4.

PMID:
18644366
6.

Calcium-channel antagonists inhibit marble-burying behavior in mice.

Egashira N, Okuno R, Abe M, Matsushita M, Mishima K, Iwasaki K, Oishi R, Nishimura R, Matsumoto Y, Fujiwara M.

J Pharmacol Sci. 2008 Sep;108(1):140-3. Epub 2008 Aug 30.

7.

Effects of agents targeting glutamatergic systems on marble-burying behavior.

Iijima M, Kurosu S, Chaki S.

Neurosci Lett. 2010 Mar 3;471(2):63-5. doi: 10.1016/j.neulet.2009.12.048. Epub 2009 Dec 28.

PMID:
20036313
8.

Effects of glutamate-related drugs on marble-burying behavior in mice: implications for obsessive-compulsive disorder.

Egashira N, Okuno R, Harada S, Matsushita M, Mishima K, Iwasaki K, Nishimura R, Oishi R, Fujiwara M.

Eur J Pharmacol. 2008 May 31;586(1-3):164-70. doi: 10.1016/j.ejphar.2008.01.035. Epub 2008 Feb 5.

PMID:
18423440
9.

Effect of ritanserin and leuprolide alone and combined on marble-burying behavior of mice.

Gaikwad U, Parle M, Kumar A, Gaikwad D.

Acta Pol Pharm. 2010 Sep-Oct;67(5):523-7.

10.

Effects of Psilocybe argentipes on marble-burying behavior in mice.

Matsushima Y, Shirota O, Kikura-Hanajiri R, Goda Y, Eguchi F.

Biosci Biotechnol Biochem. 2009 Aug;73(8):1866-8. Epub 2009 Aug 7.

11.

Involvement of the sigma1 receptor in inhibiting activity of fluvoxamine on marble-burying behavior: comparison with paroxetine.

Egashira N, Harada S, Okuno R, Matsushita M, Nishimura R, Mishima K, Iwasaki K, Orito K, Fujiwara M.

Eur J Pharmacol. 2007 Jun 1;563(1-3):149-54. Epub 2007 Feb 17.

PMID:
17349995
13.

Effects of the serotonin and noradrenaline reuptake inhibitor (SNRI) milnacipran on marble burying behavior in mice.

Sugimoto Y, Tagawa N, Kobayashi Y, Hotta Y, Yamada J.

Biol Pharm Bull. 2007 Dec;30(12):2399-401.

14.
15.

GABA receptor alterations after chronic lithium administration. Comparison with carbamazepine and sodium valproate.

Motohashi N.

Prog Neuropsychopharmacol Biol Psychiatry. 1992 Jul;16(4):571-9.

PMID:
1322549
16.

Neurosteroids modulate compulsive and persistent behavior in rodents: implications for obsessive-compulsive disorder.

S N U, J M V, N S J, P V D.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Oct 1;33(7):1161-6. doi: 10.1016/j.pnpbp.2009.06.013. Epub 2009 Jun 21.

PMID:
19549549
17.

Decreases in nestlet shredding of mice by serotonin uptake inhibitors: comparison with marble burying.

Li X, Morrow D, Witkin JM.

Life Sci. 2006 Mar 20;78(17):1933-9. Epub 2005 Sep 22.

PMID:
16182315
18.

Effect of paroxetine on marble-burying behavior in mice.

Shinomiya K, Fujii Y, Sugimoto Y, Azuma N, Tokunaga S, Kitazumi K, Kamei C.

Methods Find Exp Clin Pharmacol. 2005 Dec;27(10):685-7.

PMID:
16395417
20.

Effects of agomelatine in a murine model of obsessive-compulsive disorder: interaction with meta-chlorophenylpiperazine, bicuculline, and diazepam.

Bhutada P, Dixit P, Thakur K, Deshmukh P, Kaulaskar S.

Kaohsiung J Med Sci. 2013 Jul;29(7):362-7. doi: 10.1016/j.kjms.2012.11.003. Epub 2013 Apr 4.

Supplemental Content

Support Center